US Pre-Market SEC Filings Roundup — July 28, 2026

27-07-2026

10% owner SNOW ROTHSCHILD ACQUISITION SPONSOR LLC disposed of 100,000 Class B Ordinary Shares.

• · 10% owner SNOW ROTHSCHILD ACQUISITION SPONSOR LLC disposed of 100,000 Class B Ordinary Shares

27-07-2026

VP Contactor Business Unit SPORCK ALISTAIR N had withheld for taxes 133 Common Stock at $77.48 (~$10.3K). SPORCK ALISTAIR N holds 25,547 shares after the transaction.

• · VP Contactor Business Unit SPORCK ALISTAIR N had withheld for taxes 133 Common Stock at $77.48 (~$10.3K)

27-07-2026

Director Aghazadeh Behzad was awarded 14,725 Stock Option (Right to Buy).

• · Director Aghazadeh Behzad was awarded 14,725 Stock Option (Right to Buy)

27-07-2026

See Remarks Frangou Angeliki bought 1,131 Common Unit at $748,119.00 (~$846M). Frangou Angeliki holds 4,778,836 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · See Remarks Frangou Angeliki bought 1,131 Common Unit at $748,119.00 (~$846M)
• · See Remarks Frangou Angeliki bought 1,084 Common Unit at $79.02 (~$85.7K)
• · See Remarks Frangou Angeliki bought 1,053 Common Unit at $77.64 (~$81.8K)

27-07-2026

10% owner Innovative Cellular Therapeutics Holdings Ltd disposed of 44,000 Common Stock. Innovative Cellular Therapeutics Holdings Ltd holds 2,774,980 shares after the transaction.

• · 10% owner Innovative Cellular Therapeutics Holdings Ltd disposed of 44,000 Common Stock

27-07-2026

Co-President Koester Michael E was awarded 16,477 Shares of Common Stock, par value $0.001 per share at $24.29 (~$400K). Koester Michael E holds 111,471 shares after the transaction.

• · Co-President Koester Michael E was awarded 6,281 Shares of Common Stock, par value $0.001 per share at $24.29 (~$153K)
• · Co-President Koester Michael E was awarded 16,477 Shares of Common Stock, par value $0.001 per share at $24.29 (~$400K)

27-07-2026

COO, Risk Exchange Sternberg Matthew David sold 17,568 Class A Common Shares at $14.64 (~$257K). Sternberg Matthew David holds 596,482 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · COO, Risk Exchange Sternberg Matthew David had withheld for taxes 3,910 Class A Common Shares at $13.77 (~$53.8K)
• · COO, Risk Exchange Sternberg Matthew David sold 17,568 Class A Common Shares at $14.64 (~$257K)

27-07-2026

Chairperson & CEO ROTHBLATT MARTINE A exercised/converted 9,500 Common Stock at $135.42 (~$1.29M). 11 transactions reported in total. ROTHBLATT MARTINE A holds 324,443 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Chairperson & CEO ROTHBLATT MARTINE A exercised/converted 9,500 Common Stock at $135.42 (~$1.29M)
• · Chairperson & CEO ROTHBLATT MARTINE A sold 680 Common Stock at $525.81 (~$358K)
• · Chairperson & CEO ROTHBLATT MARTINE A sold 890 Common Stock at $527.14 (~$469K)
• · Chairperson & CEO ROTHBLATT MARTINE A sold 650 Common Stock at $528.51 (~$344K)
• · Chairperson & CEO ROTHBLATT MARTINE A sold 1,797 Common Stock at $529.75 (~$952K)
• · Chairperson & CEO ROTHBLATT MARTINE A sold 1,121 Common Stock at $530.49 (~$595K)
• · Chairperson & CEO ROTHBLATT MARTINE A sold 1,836 Common Stock at $531.65 (~$976K)
• · Chairperson & CEO ROTHBLATT MARTINE A sold 1,529 Common Stock at $532.38 (~$814K)

27-07-2026

Director GEYGAN JEFFREY RICHART was awarded 105,263 Common stock, par value $0.0001 per share. GEYGAN JEFFREY RICHART holds 3,231,969 shares after the transaction.

• · Director GEYGAN JEFFREY RICHART was awarded 105,263 Common stock, par value $0.0001 per share
• · Director GEYGAN JEFFREY RICHART disposed of 4,760 Common stock, par value $0.0001 per share

27-07-2026

10% owner White Lion Capital LLC sold 130,112 Common Stock at $0.07 (~$9.11K). White Lion Capital LLC holds 2,789,439 shares after the transaction.

• · 10% owner White Lion Capital LLC sold 80,449 Common Stock at $0.07 (~$5.63K)
• · 10% owner White Lion Capital LLC sold 130,112 Common Stock at $0.07 (~$9.11K)

27-07-2026

Director MCKENZIE OBIE was awarded 24,999 Common Stock. MCKENZIE OBIE holds 74,996 shares after the transaction.

• · Director MCKENZIE OBIE was awarded 24,999 Common Stock

27-07-2026

Unilever PLC filed this 425 communication in connection with the proposed business combination between McCormick & Company, Inc. and Sandman Corporation, an indirect wholly owned subsidiary of Unilever. The transaction involves the separation of Unilever Foods from Unilever and its combination with McCormick. The filing contains extensive cautionary language regarding forward-looking statements and risks, but does not disclose any specific financial terms, deal value, or performance metrics.

• · The transaction is structured as a business combination between McCormick and Sandman Corporation (an indirect wholly owned subsidiary of Unilever).
• · The filing serves as a solicitation of proxies from McCormick's shareholders in connection with the proposed transaction.
• · The parties intend to file a registration statement on Form S-4 (McCormick) and a registration statement on Form 10 (Unilever Foods entity) with the SEC.
• · The filing includes a cautionary statement regarding forward-looking statements and identifies numerous risks including failure to obtain regulatory approvals, McCormick shareholder approval, and financing.

28-07-2026

TIM S.A. reported its quarterly financial information for the period ended June 30, 2026, showing a mixed performance. Trade accounts receivable increased 3.1% to R$5.26 billion (consolidated) from R$5.04 billion at year-end 2025, driven by growth in billed and unbilled services. However, cash and cash equivalents declined sharply by 61.4% to R$33.2 million (parent company) from R$85.9 million, and the provision for expected credit losses rose 6.9% to R$751.1 million, indicating deteriorating collection quality.

• · Parent company gross accounts receivable increased to R$5.95 billion from R$5.74 billion at Dec 2025.
• · Overdue accounts >120 days rose to R$735.9 million (parent) from R$685.0 million at Dec 2025.
• · Parent company inventory of cell phones and tablets increased 21.2% to R$326.7 million from R$269.6 million.
• · Parent company free availability financial investments (CDBs/Repurchases) decreased to R$2.52 billion from R$3.52 billion at Dec 2025.
• · Consolidated FUNCINE investment increased to R$29.6 million from R$26.3 million at Dec 2025.

28-07-2026

Gen Digital Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders, to be held virtually on September 9, 2026. The meeting will include the election of nine director nominees, ratification of KPMG LLP as independent auditor for FY2027, and an advisory vote on executive compensation. The filing details the company's executive compensation program, which emphasizes at-risk, performance-based pay with capped payouts, robust clawback and stock ownership policies, and a 'double-trigger' change-in-control provision.

• · The record date for voting is July 14, 2026.
• · The Board recommends a vote FOR all three proposals: election of directors, ratification of KPMG, and advisory vote on executive compensation.
• · The Compensation and Leadership Development Committee incorporated responsible business metrics into the annual incentive plan for FY26.
• · The company maintains a policy requiring stockholder approval of any cash severance benefits exceeding 2.99 times the sum of base salary plus target bonus.
• · All current directors attended at least 75% of meetings held.
• · The Technology and Cybersecurity Committee was dissolved in June 2025.
• · On July 18, 2025, Susan P. Barsamian was appointed Lead Independent Director and Vincent Pilette was named Chair of the Board.

28-07-2026

Clinuvel Pharmaceuticals Limited filed a Form 6-K with the SEC on July 28, 2026, attaching a press release providing an update on SCENESSE® in vitiligo. The filing does not disclose specific financial results or performance metrics, making it a regulatory update rather than a comprehensive financial report.

• · The press release is dated July 28, 2026.
• · The filing references an Australian Securities Exchange announcement attached as Exhibit 99.1.
• · No financial figures or performance metrics are provided in this filing.

28-07-2026

ProMIS Neurosciences reported positive blinded six-month interim data from the PRECISE-AD Phase 1b trial of PMN310 in 136 early Alzheimer's patients. The drug showed a favorable safety profile with no ARIA-E cases, 4.4% total ARIA (all mild and asymptomatic), and early biomarker movement (68.5% of patients had a decline in plasma pTau217, 62.5% in CSF MTBR-tau243). However, these are blinded, pooled interim observations—treatment allocations are unknown—and trends may not reflect clinical efficacy; unblinded 12-month topline results are expected Q1 2027.

• · No ARIA-E observed across any genotype, including high-risk APOE4 carriers.
• · No treatment-related serious adverse events or drug-related discontinuations reported.
• · Trial is 3:1 active-to-placebo randomized, blinded.
• · Blinded biomarker observations are not a determination of efficacy and may not reflect clinical effects.
• · Unblinded 12-month topline data expected Q1 2027.
• · Company hosted a virtual webinar on July 28, 2026 with key opinion leaders.

28-07-2026

Menora Mivtachim Holdings Ltd. and its subsidiaries filed a Schedule 13G/A with the SEC on July 28, 2026, disclosing aggregate beneficial ownership of 961,373 ordinary shares of Ellomay Capital Ltd., representing 6.97% of the 13,783,230 shares outstanding as of July 26, 2026. The filing is an amendment to a prior 13G and reflects a slight decrease in ownership from the previous filing, as the group's stake remains below the 10% threshold.

• · The filing is an amendment to a Schedule 13G originally filed on August 4, 2025, with a joint filing agreement dated July 28, 2025.
• · The securities are held for the benefit of insurance policy holders, portfolio account owners, and members of provident or pension funds.
• · Menora Mivtachim Holdings Ltd. disclaims beneficial ownership except for its pecuniary interest.
• · The filing is made under Rule 13d-1(c), indicating the filer is a passive investor not seeking to change or influence control.

28-07-2026

Equinor ASA disclosed transactions under the third tranche of its 2026 share buy-back programme, repurchasing 220,000 shares on the Oslo Stock Exchange (OSE) over July 23-24, 2026, at a weighted average price of NOK 391.4877 per share, for a total consideration of NOK 86,127,300. No transactions were executed on CEUX or TQEX during this period.

• · Daily weighted average share price on OSE was NOK 394.8606 on July 23 and NOK 388.6770 on July 24.
• · No buy-backs were executed on CEUX or TQEX during the reported period.

28-07-2026

ING Groep N.V. filed a Form 6-K with the SEC on July 28, 2026, attaching a press release of the same date. The filing is a routine foreign issuer report and does not contain any financial results or material operational updates.

28-07-2026

Y.D. More Investments Ltd. and related entities filed a Schedule 13G/A with the SEC on July 28, 2026, disclosing aggregate beneficial ownership of 703,048 ordinary shares of TAT Technologies Ltd., representing 5.42% of the 12,983,137 shares outstanding as of June 30, 2026. The filing is an amendment to a prior 13G and reflects no change in the reporting persons' holdings or percentage ownership from the previous filing, indicating a stable, passive investment position.

• · The filing is an amendment (Schedule 13G/A) to a prior 13G filed on September 12, 2024.
• · The securities are held for the benefit of provident/pension fund beneficiaries, mutual fund investors, and portfolio management clients, not for the purpose of changing or influencing control of the issuer.
• · More Investment House Portfolio Management Ltd. reported 0 shares and 0% ownership.
• · Y.D. More Investments Ltd. is controlled through a voting agreement among Yosef Meirov (directly and through B.Y.M.), Benjamin Meirov, Yosef Levy, and Eli Levy (through Elldot Ltd.).
• · More Provident Funds and Pension Ltd. is a majority-owned subsidiary of Y.D. More (65.75% ownership).

28-07-2026

UPS reported Q2 2026 consolidated revenues of $22.8B, up from $21.2B in Q2 2025, with non-GAAP adjusted operating profit of $2.1B, up from $1.9B. However, GAAP operating profit fell sharply to $930M from $1.8B due to $891M in after-tax transformation charges, and GAAP diluted EPS dropped to $0.71 from $1.65. The company raised full-year 2026 guidance: revenue to ~$91.2B, non-GAAP adjusted operating profit to ~$8.65B, and non-GAAP adjusted diluted EPS to ~$7.22.

• · GAAP results included after-tax transformation charges of $891M ($1.05 per diluted share) primarily from employee separation costs related to the Driver Choice Program.
• · U.S. Domestic Segment GAAP operating margin was 0.1%; non-GAAP adjusted operating margin was 8.0%.
• · International Segment operating margin on both GAAP and non-GAAP adjusted basis was 12.4%.
• · Supply Chain Solutions operating margin on both GAAP and non-GAAP adjusted basis was 10.2%.
• · In first six months of 2026, UPS achieved ~$1.2B in program benefits from transformation initiatives; expects ~$3B in full-year 2026 benefits.
• · Transformation initiatives expected to conclude by 2027.
• · UPS confirms expected 2026 capital expenditures of ~$3.0B and dividend payments of ~$5.4B.
• · Effective tax rate for 2026 still expected to be approximately 23.0%.
• · 2025 full-year revenue was $88.7B.

28-07-2026

Maison Solutions Inc. (MSS) and its wholly owned subsidiary AZLL LLC entered into a Formation, Subscription and Software Contribution Agreement (dated July 22, 2026) to form Maison AI Limited in Hong Kong. AZLL will subscribe for 200 of 222 issued ordinary shares (approximately 90.0901%) in consideration for MSS's Software valued at US$2,000,000, while two Chinese investors (Hangzhou Shengxianbao Technology Co., Ltd. and Yiwu Yanghan E-Commerce Firm) will each subscribe for 11 shares (approximately 4.9550% each) for cash of US$110,000 each (US$220,000 aggregate) payable in six monthly installments beginning on or about September 1, 2026; however, the cash subscribers’ shares will be partly paid until full payment and Closing is subject to conditions and may be terminated if not closed by March 31, 2027.

• · The cash subscriptions of US$110,000 each are payable in six monthly installments with the first installment due on the later of September 1, 2026 and the fifth Business Day after incorporation and bank account availability.
• · MSS and its subsidiaries retain a perpetual, worldwide, non-exclusive, irrevocable, royalty-free right to use, host, operate, maintain, modify and integrate the Software for internal business purposes; MSS may not sell or sublicense the Software to unrelated third parties except with the Company’s written consent.
• · Closing is subject to customary conditions (incorporation, approvals, release of any liens on the Software) and the Shareholders Agreement has not been executed and will only become effective if executed by all shareholders at Closing.
• · The Formation Agreement may be terminated if Closing has not occurred by March 31, 2027.
• · Until fully paid, the subscribers’ Shares are partly paid shares and are subject to Articles, this Agreement and the Shareholders Agreement; Articles will include calls, suspension, forfeiture and other provisions under Hong Kong law.

28-07-2026

Y.D. More Investments Ltd. and related entities filed an amended Schedule 13G with the SEC on July 28, 2026, disclosing aggregate beneficial ownership of 636,066 shares of Odysight.ai Inc. common stock as of June 30, 2026, representing 3.79% of the outstanding shares. The filing is a routine update of beneficial ownership and does not indicate any change in control intent.

• · The filing is an amendment (13G/A) to a prior Schedule 13G, indicating an update to beneficial ownership information.
• · The reporting persons certify that the securities were not acquired with the purpose of changing or influencing control of the issuer.
• · More Provident Funds & Pension Ltd. is a majority-owned subsidiary of Y.D. More Investments Ltd. (65.75% ownership).
• · More Mutual and More Investment are wholly-owned subsidiaries of Y.D. More.
• · Y.D. More is controlled through a voting agreement among Yosef Meirov (directly and through B.Y.M.), Benjamin Meirov, Yosef Levy, and Eli Levy (through Elldot Ltd.).

28-07-2026

Ecopetrol S.A. filed a Form 6-K with the SEC for the month of July 2026, signed by CFO Alfonso Camilo Barco. The filing is a routine foreign private issuer report and contains no financial results, material events, or operational updates.

28-07-2026

CenterPoint Energy reported net income of $244M for Q2 2026, up 23.2% from $198M in Q2 2025, driven by higher utility revenues and lower natural gas costs. However, the company recorded a $151M loss on equity securities in Q2 2026 versus a $43M gain in the prior-year period, partially offset by a $148M gain on indexed debt securities. For the six months ended June 30, 2026, net income rose 13.1% to $560M from $495M, while basic EPS increased to $0.85 from $0.76.

• · Weighted average diluted shares outstanding increased to 666M in Q2 2026 from 654M in Q2 2025.
• · Investment in equity securities decreased to $404M as of June 30, 2026 from $510M at December 31, 2025.
• · Current assets held for sale remained substantial at $2,617M as of June 30, 2026, compared to $2,669M at year-end 2025.
• · Regulatory assets (non-current) increased to $3,619M from $3,005M, largely due to VIE-related amounts.
• · Property, plant and equipment, net grew 3.9% to $35,383M from $34,056M.
• · The company recorded a loss on sale of $0 in the six months ended June 30, 2026 versus a $43M loss in the prior-year period.
• · Interest expense on Securitization Bonds surged to $21M in Q2 2026 from $4M in Q2 2025.
• · Cash and cash equivalents increased to $49M from $38M at year-end 2025.

28-07-2026

Baidu, Inc. filed a Form 6-K with the SEC on July 28, 2026, for the month of July 2026, attaching a press release as Exhibit 99.1. The filing is a routine foreign private issuer report under Rule 13a-16 or 15d-16, signed by CFO Haijian He. No specific financial results or material events are detailed in the filing itself, only the cover and signature pages.

• · The filing is a Form 6-K for the month of July 2026.
• · Commission File Number: 000-51469.
• · The registrant files annual reports under Form 20-F.
• · The press release (Exhibit 99.1) is referenced but not included in the provided text.

28-07-2026

Axalta reported Q2 2026 net sales of $1.35B (+3% YoY) and record Adjusted EBITDA of $305M (+5% YoY) with a 22.7% margin. However, GAAP net income fell 19% YoY to $89M due to $31M in merger-related costs, and diluted EPS declined to $0.41 from $0.50. The company also highlighted its pending merger of equals with AkzoNobel, with a special general meeting scheduled for August 5, 2026.

• · Total net leverage of 2.2x, the lowest in Axalta's history.
• · Performance Coatings segment net sales $872M (+4% YoY) with organic growth in Europe and Asia, partially offset by lower volumes in North America.
• · Mobility Coatings Light Vehicle net sales declined slightly year over year.
• · Industrial net sales +2% YoY to $327M with positive volume growth in Europe and Asia offsetting lower North America volumes.
• · Q3 2026 guidance: Adjusted EBITDA $295M-$305M; FY 2026 guidance: Adjusted EBITDA $1.14B-$1.17B, Adjusted Diluted EPS $2.55-$2.70, Free Cash Flow >$500M.
• · Special General Meeting to approve AkzoNobel merger scheduled for August 5, 2026.
• · Merger-related costs of $31M impacted net income in Q2 2026.

28-07-2026

GDS Holdings Limited filed a Form 6-K with the SEC on July 28, 2026, attaching a press release announcing the release of its 2025 Sustainability Report and the achievement of an MSCI AAA rating. No financial results or material operational changes were disclosed in this filing.

• · The filing is a Form 6-K for the month of July 2026.
• · The company achieved an MSCI AAA rating, the highest possible ESG rating from MSCI.
• · The press release is included as Exhibit 99.1.

28-07-2026

Ceragon Networks Ltd. disclosed via Form 6-K that it has received approximately $120 million in orders from operators in India year-to-date through July 2026. The filing, signed by CFO Ronen Stein, highlights a significant revenue inflow from the Indian market but provides no comparative prior-period data or other financial metrics.

• · The orders are from operators in India.
• · The disclosure is made as an exhibit to a Form 6-K filed with the SEC.
• · No prior-year or prior-period order data is provided for comparison.

28-07-2026

Autohome Inc. filed a Form 6-K with the SEC for July 2026, attaching a press release as Exhibit 99.1. The filing is a routine foreign private issuer report and does not contain any financial results or material business updates beyond the press release.

• · Filing date: July 28, 2026
• · Commission file number: 001-36222
• · Address: 18th Floor Tower B, CEC Plaza, 3 Dan Ling Street, Haidian District, Beijing 100080, China
• · Exhibit 99.1 is a press release (content not provided in the filing excerpt)

28-07-2026

Hilton reported strong Q2 2026 results with diluted EPS of $2.10 ($2.29 adjusted) and net income of $482 million, up from $1.84 and $442 million in Q2 2025. System-wide comparable RevPAR grew 3.9% YoY, and the development pipeline reached a record 541,300 rooms. However, the company's full-year RevPAR guidance of 3.0%-3.5% growth implies a deceleration in the second half, and Q4 is expected to be affected by unfavorable calendar shifts and midterm elections.

• · Q2 2026 net income of $482M benefited from $17M of non-RevPAR items pulled forward from H2.
• · Full-year 2026 net income guidance range: $1,883M to $1,911M.
• · Full-year 2026 Adjusted EBITDA guidance range: $4,040M to $4,080M.
• · Full-year 2026 diluted EPS guidance: $8.22 to $8.35; adjusted: $8.89 to $9.01.
• · Q3 2026 RevPAR growth guidance: approximately 4.0% YoY.
• · Q3 2026 net income guidance: $502M to $516M; Adjusted EBITDA: $1,035M to $1,055M.
• · Total debt of $13.4B with weighted average interest rate of 5.03%; no material maturities until April 2029 except $600M Senior Notes due April 2027.
• · Revolving credit facility undrawn with $1,894M available capacity as of June 30, 2026.
• · Quarterly dividend of $0.15 per share declared for September 30, 2026 payment.
• · Average share repurchase price in Q2 2026: $326.99 per share.
• · Full-year 2026 net unit growth guidance: 6.0% to 7.0%.
• · Full-year 2026 G&A expense guidance: approximately $400M.
• · Full-year 2026 contract acquisition costs and capex guidance: approximately $300M.